Shares of AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report) passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $3.07 and traded as high as $5.14. AIkido Pharma shares last traded at $4.78, with a volume of 184,078 shares changing hands.
AIkido Pharma Trading Down 2.5 %
The firm’s 50-day moving average price is $5.73 and its 200 day moving average price is $3.09. The company has a market capitalization of $21.39 million, a price-to-earnings ratio of -1.01 and a beta of 0.93.
About AIkido Pharma
AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
See Also
- Five stocks we like better than AIkido Pharma
- Financial Services Stocks Investing
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- The 3 Most Talked About Investments on WallStreetBets Right Now
- With Risk Tolerance, One Size Does Not Fit All
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
